ICRM director-general to give lecture about cancer research in India at AACR conference

Vishwa Mohan Katoch, M.D., will give a special lecture entitled "Cancer Research in India: Future Directions" at the AACR International Conference on New Horizons in Cancer Research: Biology to Prevention to Therapy, Dec. 13-16, 2011, in Gurgaon, Delhi (NCR), India.

Katoch is secretary to the Government of India Department of Health Research and director-general of the Indian Council of Medical Research (ICRM) in New Delhi, India.

The American Association for Cancer Research welcomes media attendance at this special lecture, which will be held on Friday, Dec. 16 from 9:10 a.m. to 9:30 a.m., in the Pearl Ballroom of the Leela Kempinski Gurgaon.

"This is an exciting time for cancer research. New technologies and new disciplines are helping to accelerate the development of new treatments, and Indian scientists and clinicians are making great contributions to the field," said Margaret Foti, Ph.D., M.D. (h.c.), chief executive officer of the AACR. "We are honored to hear Dr. Katoch's vision for the future of cancer research in India, which will undoubtedly provide a dynamic platform for the establishment of new collaborations on an international scale."

Source: American Association for Cancer Research

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

Sign in to keep reading

We're committed to providing free access to quality science. By registering and providing insight into your preferences you're joining a community of over 1m science interested individuals and help us to provide you with insightful content whilst keeping our service free.

or

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
IFITM3 found to be critical regulator of immunotherapy sensitivity in small cell lung cancer